Cancer Control / Symptom Management

Please click on the protocol number for additional information.

CALGB 90202: Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

MAYO RC05CB : Epoetin alfa or Darbepoetin alfa in Treating Patients With Anemia Caused by Chemotherapy

NCCTG E5597: Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer

NCCTG N04CA: Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer

NCCTG N04C2: Octreotide in Treating Patients With Cancer-Related Malignant Ascites

NCCTG N05C5: Pyridoxine and Topical Urea in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Colorectal Cancer or Breast Cancer

SWOG S0424: Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men

Please contact the research office for more information.